Pieters R - Search Results

1

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.

Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG. Pieters R, et al. J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8. J Clin Oncol. 2019. PMID: 31283407 Clinical Trial.

2

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.

Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ. Pieters R, et al. Leukemia. 1998 Sep;12(9):1344-8. doi: 10.1038/sj.leu.2401129. Leukemia. 1998. PMID: 9737681

3

Biological and therapeutic aspects of infant leukemia.

Biondi A, Cimino G, Pieters R, Pui CH. Biondi A, et al. Among authors: pieters r. Blood. 2000 Jul 1;96(1):24-33. Blood. 2000. PMID: 10891426 Free article. Review. No abstract available.

4

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

Schmiegelow K, Nyvold C, Seyfarth J, Pieters R, Rottier MM, Knabe N, Ryder LP, Madsen HO, Svejgaard A, Kaspers GJ. Schmiegelow K, et al. Among authors: pieters r. Leukemia. 2001 Jul;15(7):1066-71. doi: 10.1038/sj.leu.2402144. Leukemia. 2001. PMID: 11455975

5

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Among authors: pieters r. Nat Genet. 2002 Jan;30(1):41-7. doi: 10.1038/ng765. Epub 2001 Dec 3. Nat Genet. 2002. PMID: 11731795

6

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Among authors: pieters r. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

7

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE. Den Boer ML, et al. Among authors: pieters r. J Clin Oncol. 2003 Sep 1;21(17):3262-8. doi: 10.1200/JCO.2003.11.031. J Clin Oncol. 2003. PMID: 12947061

8

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.

Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R. Ramakers-van Woerden NL, et al. Among authors: pieters r. Leukemia. 2004 Mar;18(3):521-9. doi: 10.1038/sj.leu.2403253. Leukemia. 2004. PMID: 14712291

9

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Holleman A, et al. Among authors: pieters r. N Engl J Med. 2004 Aug 5;351(6):533-42. doi: 10.1056/NEJMoa033513. N Engl J Med. 2004. PMID: 15295046 Free article.

10

Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.

Hotfilder M, Röttgers S, Rosemann A, Schrauder A, Schrappe M, Pieters R, Jürgens H, Harbott J, Vormoor J. Hotfilder M, et al. Among authors: pieters r. Cancer Res. 2005 Feb 15;65(4):1442-9. doi: 10.1158/0008-5472.CAN-04-1356. Cancer Res. 2005. PMID: 15735032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

994 results

Search Page